IRF-5 Is a Mediator of the Death Receptor-induced Apoptotic Signaling Pathway*

The efficient and regulated response to cellular stress is coordinated by a genetic regulatory network in which a given transcription factor controls the expression of diverse target genes depending on the cell type and/or nature of the stimuli. The tumor suppressor p53 is thought to preferentially regulate the balance between cell survival and death. The interferon regulatory factor 5 (IRF-5), known to be involved in the innate immune response to pathogens, is also a critical regulator of DNA damage-induced apoptosis. Here, we provide direct evidence that IRF-5 promotes apoptosis upon signaling through tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptors (DR). We report that IRF-5 sensitizes tumor cells to TRAIL-induced apoptosis and cell death that is further enhanced by type I interferons. Cells deficient of IRF-5 gave a significantly diminished response to these agents. IRF-5 is involved in DR signaling upstream of caspase 8, in part because of an IRF-5-dependent increase in caspase 8 activation. We provide evidence that TRAIL induces a signaling cascade that leads to the phosphorylation and nuclear localization of IRF-5, resulting in transactivation of key DR signaling components. The results presented here identify IRF-5 as a new mediator of DR signaling and provides molecular insight into the mechanism of TRAIL-induced IRF-5 signaling.

[1]  T. Taniguchi,et al.  A cell-type-specific requirement for IFN regulatory factor 5 (IRF5) in Fas-induced apoptosis , 2008, Proceedings of the National Academy of Sciences.

[2]  G. Jaffe,et al.  Caspase-8-mediated apoptosis in human RPE cells. , 2007, Investigative ophthalmology & visual science.

[3]  K. Honda,et al.  Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression , 2007, Proceedings of the National Academy of Sciences.

[4]  D. Lawrence,et al.  Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand* , 2005, Journal of Biological Chemistry.

[5]  B. Barnes,et al.  Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. , 2005, Cancer research.

[6]  S. Gibson,et al.  Transcription Factor NF-κB Differentially Regulates Death Receptor 5 Expression Involving Histone Deacetylase 1 , 2005, Molecular and Cellular Biology.

[7]  A. Karpova,et al.  Identification of TRAIL as an Interferon Regulatory Factor 3 Transcriptional Target , 2005, Journal of Virology.

[8]  Katherine E. M. Hoops,et al.  Two Discrete Promoters Regulate the Alternatively Spliced Human Interferon Regulatory Factor-5 Isoforms , 2005, Journal of Biological Chemistry.

[9]  R. Zeillinger,et al.  Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian Cancer , 2005, Molecular Cancer Research.

[10]  D. Golenbock,et al.  The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling* , 2005, Journal of Biological Chemistry.

[11]  J. Houghton,et al.  Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines , 2005, Oncogene.

[12]  Tak W. Mak,et al.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.

[13]  S. Lowe,et al.  DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis , 2005, Molecular and Cellular Biology.

[14]  J. Hiscott,et al.  A CRM1-dependent Nuclear Export Pathway Is Involved in the Regulation of IRF-5 Subcellular Localization* , 2005, Journal of Biological Chemistry.

[15]  G. Barber,et al.  A FADD-dependent innate immune mechanism in mammalian cells , 2004, Nature.

[16]  Q. Deveraux,et al.  Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle. , 2004, Molecular biology of the cell.

[17]  S. Hanash,et al.  Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection* , 2004, Journal of Biological Chemistry.

[18]  W. El-Deiry,et al.  Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity , 2004, Molecular and Cellular Biology.

[19]  H. Gronemeyer,et al.  Tumor suppressor IRF‐1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL , 2004, The EMBO journal.

[20]  A. Ashkenazi,et al.  Targeting death receptors in cancer with Apo2L/TRAIL. , 2004, Current opinion in pharmacology.

[21]  W. Winkelmann,et al.  Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells , 2003, International journal of cancer.

[22]  P. Pitha,et al.  Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. , 2003, Cancer research.

[23]  Hideo Negishi,et al.  Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence , 2003, Nature.

[24]  K. Eguchi,et al.  Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation , 2003, Oncogene.

[25]  P. Pitha,et al.  Multiple Regulatory Domains of IRF-5 Control Activation, Cellular Localization, and Induction of Chemokines That Mediate Recruitment of T Lymphocytes , 2002, Molecular and Cellular Biology.

[26]  H. Döhner,et al.  Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. , 2002, Blood.

[27]  Yusuke Nakamura,et al.  Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53 , 2002, Oncogene.

[28]  Tatsushi Yoshida,et al.  Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL‐R2 gene1 , 2001, FEBS letters.

[29]  T. Taniguchi,et al.  Antiviral response by natural killer cells through TRAIL gene induction by IFN–α/β  , 2001, European journal of immunology.

[30]  P. Moore,et al.  Virus-specific Activation of a Novel Interferon Regulatory Factor, IRF-5, Results in the Induction of Distinct Interferon α Genes* , 2001, The Journal of Biological Chemistry.

[31]  T. Taniguchi,et al.  The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice. , 2001, Cytokine & growth factor reviews.

[32]  R. K Srivastava,et al.  Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways , 2001, Oncogene.

[33]  A. Winoto,et al.  FADD Is Required for DR4- and DR5-mediated Apoptosis , 2000, The Journal of Biological Chemistry.

[34]  W. El-Deiry,et al.  Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site , 2000, Oncogene.

[35]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[36]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[37]  D. Goeddel,et al.  FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. , 1998, Science.

[38]  S. Ferrini,et al.  Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE) , 2004, Cell Death and Differentiation.